Immediate Impact
2 from Science/Nature 57 standout
Citing Papers
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 Standout
Works of Astrid Trion being referenced
No Effect of C-Reactive Protein on Early Atherosclerosis Development in Apolipoprotein E*3-Leiden/Human C-Reactive Protein Transgenic Mice
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Astrid Trion | 97 | 83 | 54 | 79 | 5 | 313 | |
| Silvia Münster | 56 | 65 | 104 | 98 | 7 | 360 | |
| Neel Gadhoke | 104 | 47 | 16 | 76 | 7 | 311 | |
| Maria Silvia Tommasi | 52 | 179 | 42 | 52 | 8 | 324 | |
| Jean‐Michel Raoult | 57 | 35 | 99 | 76 | 6 | 333 | |
| Elisa Bertacco | 53 | 71 | 85 | 43 | 12 | 325 | |
| Ana Persson | 58 | 55 | 13 | 90 | 7 | 293 | |
| Qiu Jin Chen | 55 | 43 | 20 | 110 | 7 | 334 | |
| Rita Lippai | 50 | 48 | 10 | 82 | 10 | 325 | |
| Robert Lattes | 51 | 20 | 24 | 39 | 6 | 290 | |
| Annalisa Foschi | 65 | 24 | 90 | 77 | 10 | 316 |
All Works
Loading papers...